Open AccessAlzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites
Author(s) -
Elizabeth K. Rhodus,
Paul S. Aisen,
J.D. Grill,
D.M. Rentz,
R.C. Petersen,
R.A. Sperling,
S.P. Salloway,
D. Pierce,
Rema Raman
Publication year - 2022
Publication title -
the journal of prevention of alzheimer's disease/jpad
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.733
H-Index - 13
eISSN - 2426-0266
pISSN - 2274-5807
DOI - 10.14283/jpad.2022.79
Subject(s) - pandemic , covid-19 , clinical trial , alzheimer's disease , disease , sample (material) , adaptation (eye) , medicine , psychology , gerontology , neuroscience , outbreak , virology , infectious disease (medical specialty) , chemistry , chromatography
The COVID-19 pandemic created challenges in clinical research operations that required immediate and lasting changes.